[1] 中华医学会呼吸病学分会. 中国成人社区获得性肺炎诊断和治疗指南(2016版)[J]. 中华结核和呼吸杂志,2016,39(4):253-279. [2] 董朝晖. 药物干预对呼吸内科抗生素临床选择与使用的影响分析[J]. 中国现代药物应用,2021,15(17):235-237. [3] Amalakuhan B, Echevarria KL, Restrepo MI.Managing community acquired pneumonia in the elderly the next generation of pharmacotherapy on the horizon[J]. Expert Opinion on Pharmacotherapy, 2017, 18(11): 1039-1048. [4] Feng DY, Zou XL, Zhou YQ, et al.Combined neutrophil-to-lymphocyte ratio and curb-65 score as an accurate predictor of mortality for community-acquired pneumonia in the elderly[J]. International Journal of General Medicine, 2021, 14: 1133-1139. [5] 余学庆,谢洋,李建生. 社区获得性肺炎中医诊疗指南(2018修订版)[J]. 中医杂志,2019,60(4):350-360. [6] Sun Y, Li H, Pei Z, et al.Incidence of communityacquired pneumonia in urban China: A national population based study[J]. Vaccine, 2020, 38(52): 8362-8370. [7] 王晓希,贺晓芳. 益气养阴汤治疗气阴两虚型老年社区获得性肺炎的临床疗效探究[J]. 中医临床研究,2020,12(30):75-77. [8] 宋国永,张永明. 解毒排脓汤治疗痰热壅肺型老年社区获得性肺炎的效果及对PCT、hs-CRP、血气分析指标的影响[J]. 临床医学研究与实践,2020,5(14):139-140. [9] 赵华东,齐卫平,许雪原. 银翘风热清解汤治疗老年社区获得性肺炎风热犯肺证的临床观察[J]. 中国中医药科技,2019,26(5):773-775. [10] 董尚娟,史利卿,季坤,等. 老年风温肺热病肺脾相关病机特点探讨[J]. 现代中医临床,2019,26(3):59-62. [11] 韩景献. 三焦气化失常-衰老-相关论[J]. 中医杂志,2008,49(3):200-202. [12] Kim JH.Interleukin-8 in the tumor immune niche: lessons from comparative oncology[J]. Advances in experimental medicine and biology, 2020, 1240:25-33. [13] McGroder CF, Aaron CP, Bielinski SJ, et al. Circulating adhesion molecules and subclinical interstitial lung disease: the multi-ethnic study of atherosclerosis[J]. European Respiratory Journal, 2019, 54(3): 1900295. [14] Wu M, Tong X, Wang D, et al.Soluble intercellular cell adhesion molecule-1 in lung cancer: A meta-analysis[J]. Pathology Research and Practice, 2020, 216(10): 153029. [15] Varona JF, Ortiz-Regalon R, Sanchez-Vera I, et al.Soluble ICAM 1 and vcam 1 blood levels alert on subclinical atherosclerosis in non smokers with asymptomatic metabolic syndrome[J]. Archives of Medical Research, 2019, 50(2):20-28. [16] Oleszowsky M, Seidel MF.Serum soluble vascular cell adhesion molecule-1 overexpression is a disease marker in patients with first-time diagnosed antinuclear antibodies: a prospective, observational pilot study[J]. Biomed Research International, 2018, 2018: 8286067. [17] Al-Biltagi MA, Abo-Elezz A, Abu-Ela KT, et al.The prognostic value of soluble intercellular adhesion molecule 1 plasma level in children with acute lung injury[J]. Journal of Intensive Care Medicine, 2017, 32(5): 320-325. |